3,4-di-substituted cyclobutene-1, 2-diones as CXC-chemokine receptor ligands
Details for Australian Patent Application No. 2003259302 (hide)
International Classifications
Event Publications
13 November 2003 Complete Application Filed
Priority application(s): 10/241,326 11.09.02 US; 10/208,412 30.07.02 US
25 March 2004 Application Open to Public Inspection
Published as AU-B-2003259302
13 September 2007 Assignment before Grant
Schering Corporation; Pharmacopeia Drug Discovery, Inc. The application has been assigned to Schering Corporation; Pharmacopeia, Inc.
26 June 2008 Application Accepted
Published as AU-B-2003259302
23 October 2008 Standard Patent Sealed
24 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser